Stay Up to Date! Like us on Facebook  and Twitter  for the latest news and announcements    

July 2017

by admin

Woburn, Mass.--(BUSINESS WIRE)—Courtagen Life Sciences Inc. announced today that the company will be shifting the core focus of its business to medicinal cannabis genetics and testing. As the company reorients its business to respond to the growing opportunities in the medicinal cannabis industry, the company has made the decision to wind down its diagnostic neurology testing division.

Jul 24, 2017 Comments: 0
by admin

The thoughts and prayers of the entire mitochondrial disease community are with Charlie Gard and his mother and father, Chris Gard and Connie Yates.  They have decided to withdraw their request to have little Charlie treated with an experimental therapy.  Medical experts have told the family it would not be effective for him.

Jul 24, 2017 Comments: 0
by admin
MitoAction, the Foundation for Mitochondrial Medicine and UMDF have jointly authored an editorial that was sent to major newspaper outlets across the United States.
Jul 11, 2017 Comments: 0